Clinical Trials Directory

Trials / Completed

CompletedNCT04978233

The Opal - COVID-19 Study

Use of the Opal Patient Portal Application for Daily Follow-up of People at Home With COVID-19: The Opal-COVID Feasibility Study

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Dr. Bertrand Lebouche · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In collaboration with involved healthcare professionals and a patient advisory committee, this study tests the feasibility of using the Opal smartphone app to daily capture self-reported physical and psychological symptoms and vital signs among 50 people who are self-isolating at home with COVID-19. A healthcare team at Montreal's MUHC will remotely monitor their condition and offer advice and teleconsultations, as needed.

Detailed description

In the context of the current pandemic, guidelines were issued by public health authorities to follow the progression of COVID-19 in the community, identify and treat affected people, and limit transmissions. About 90% of people with COVID-19 only exhibit mild symptoms and recover. However, a small percentage of people experience serious symptoms and require hospitalization for severe shortness of breath or low oxygen levels. The current public health protocol is to identify people with COVID-19 and isolate them from others at home to prevent the virus from spreading. Currently, there is no consensus on how to effectively follow-up and treat individuals with COVID-19 who are self-isolating at home. Research is urgently needed. This pilot study will assess the feasibility of one strategy for home-based COVID-19 follow-up . The Opal app for COVID is a mobile application that will allow the completion of a daily symptom and vital sign follow-up questionnaire that will be monitored by a healthcare team. Educational material will also be provided through the app. The study will especially assess the acceptability and usability of the smartphone app.

Conditions

Interventions

TypeNameDescription
OTHERsociodemographic and health, daily self-assessment, and feasibility of using the Opal app for COVIDThe intervention consists of having confirmed COVID-19 infected participants register for the Opal app and complete a daily questionnaire on symptoms related to their physical and mental health as well as on certain key vital signs (e.g., oxygen saturation, heart rate, temperature). A nurse will check the questionnaire results each day and determine the need for a teleconsultation with an infectious disease physician. Participants will be followed up for a minimum of 14 days, depending on their symptoms.

Timeline

Start date
2020-12-08
Primary completion
2021-03-31
Completion
2021-03-31
First posted
2021-07-27
Last updated
2021-07-27

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04978233. Inclusion in this directory is not an endorsement.